M 47 Pill - blue round, 10mm
Pill with imprint M 47 is Blue, Round and has been identified as Metoprolol Tartrate 100 mg. It is supplied by Mylan Pharmaceuticals Inc.
Metoprolol is used in the treatment of Heart Failure; Angina; High Blood Pressure; Angina Pectoris Prophylaxis; Heart Attack and belongs to the drug class cardioselective beta blockers. Risk cannot be ruled out during pregnancy. Metoprolol 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M 47






Metoprolol Tartrate
- Imprint
- M 47
- Strength
- 100 mg
- Color
- Blue
- Size
- 10.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Cardioselective beta blockers
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
-
lactose anhydrous,
silicon dioxide,
croscarmellose sodium,
hypromelloses,
magnesium stearate,
microcrystalline cellulose,
polydextrose,
polyethylene glycol,
povidone,
sodium lauryl sulfate,
titanium dioxide,
triacetin,
FD&C Blue No. 2
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00378-0047 | Mylan Pharmaceuticals Inc. |
51079-0802 (Discontinued) | UDL Laboratories Inc. |
Related images for "M 47"
More about metoprolol
- Check interactions
- Compare alternatives
- Reviews (650)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: cardioselective beta blockers
- Breastfeeding
- En español
Patient resources
- Metoprolol drug information
- Metoprolol (Intravenous) (Advanced Reading)
- Metoprolol Extended-Release Tablets
Other brands
Professional resources
- Metoprolol monograph
- Metoprolol (FDA)
- Metoprolol Succinate (FDA)
- Metoprolol Succinate ER Capsules (FDA)
- Metoprolol Succinate ER Tablets (FDA)
Other brands
Toprol-XL, Lopressor, Kapspargo Sprinkle
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.